Advanced search
Start date
Betweenand

The politics of the health industry complex in times of change

Grant number: 21/06202-0
Support Opportunities:Research Grants - Young Investigators Grants - Phase 2
Duration: May 01, 2022 - April 30, 2027
Field of knowledge:Applied Social Sciences - Administration - Public Administration
Principal Investigator:Elize Massard da Fonseca
Grantee:Elize Massard da Fonseca
Host Institution: Escola de Administração de Empresas (EAESP). Fundação Getúlio Vargas (FGV). São Paulo , SP, Brazil
Associated researchers: Francisco Inacio Pinkusfeld Monteiro Bastos ; Kenneth Shadlen
Associated research grant:15/18604-5 - Policies to increase the competitiveness of the pharmaceutical sector: Brazil's experience, AP.JP
Associated grant(s):23/01272-6 - Brazil's response to antimicrobial resistance (AMR): institutionalization and governance during public health crises, AP.R
Associated scholarship(s):23/09432-2 - The politics of financing health in the context of universal healthcare, BP.DD
23/03660-3 - Dissemination of research findings of the study "The politics of the health industry complex in times of change", BP.JC
22/16435-5 - Reforming health surveillance in Brazil, BP.MS
+ associated scholarships 22/10029-5 - Support for field research and project management, BP.TT
22/08616-0 - Building local capabilities to produce vaccines and biological medicines: Brazil in comparative perspective, BP.PD
22/07849-0 - Civil society, the COVID-19 pandemic, and universal access to medicines in Brazil: building a better framework, BP.PD
22/06672-0 - Politics and governance of drug regulation and technology transfer, BP.IC - associated scholarships

Abstract

This research will continue the study of the health industry complex (CIS), an array of instruments to align health policy with industrial policy. We began this research a decade ago, and we now aim to expand it to the case of COVID-19. The pandemic has shifted the incentives of biomedical innovation, promoted collaboration among drug regulatory agencies in ways never seen before, and reshaped the debate around access to medicine and vaccines. Notwithstanding many controversial aspects of Brazil's reaction to COVID-19, the country is exploring these novel opportunities to procure, regulate, and produce vaccines as it has for other infectious diseases. These responses-currently in the case of COVID-19 and in past with the cases of HIV and hepatitis C-have important implications for pandemic preparedness and conceptualization of health industry policies. Our research program, which will be grounded in qualitative and epidemiological analyses, is structured around three axes: (1) Politics and governance of technology transfer for pharmaceuticals, (2) Regulatory capacity building, (3) Policy and politics to ensure access to COVID-19 vaccines and hepatitis C drugs. Our team has strong international and national collaboration ties, including the LSE, the University of Michigan, and the Oswaldo Cruz Foundation (Fiocruz), Latin America's largest biomedical research institute. Together, we will produce publications to high-impact journals, train undergraduate and graduate students in different dimensions of health industry policy, and produce evidence that can shape health policy and pathways to respond to future public health crises. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Please report errors in scientific publications list using this form.